Delivery of therapeutic doses of doxorubicin to the mouse lung using lung-accumulating liposomes proves unsuccessful
- 1 October 1983
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 11 (2) , 98-101
- https://doi.org/10.1007/bf00254254
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomesEuropean Journal of Cancer and Clinical Oncology, 1982
- THE USE OF A NEW RADIOACTIVE-IODINE LABELED LIPID MARKER TO FOLLOW INVIVO DISPOSITION OF LIPOSOMES - COMPARISON WITH AN ENCAPSULATED AQUEOUS SPACE MARKER1982
- ANALYSIS OF THE FATE OF SYSTEMICALLY ADMINISTERED LIPOSOMES AND IMPLICATIONS FOR THEIR USE IN DRUG DELIVERY1982
- Liposome disposition in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicinCancer Chemotherapy and Pharmacology, 1981
- TISSUE DISTRIBUTION AND ANTI-TUMOR EFFECT OF LIPOSOME-ENTRAPPED DOXORUBICIN (ADRIAMYCIN) IN EHRLICH SOLID TUMOR-BEARING MOUSE1981
- Invitro and invivo studies with adriamycin liposomesBiochemical and Biophysical Research Communications, 1979
- Interaction of radiation and adriamycin on the EMT6 tumor as a function of tumor size and assay methodInternational Journal of Radiation Oncology*Biology*Physics, 1979
- RETENTION OF CYTOSINE-ARABINOSIDE IN MOUSE LUNG FOLLOWING INTRAVENOUS ADMINISTRATION IN LIPOSOMES OF DIFFERENT SIZE1979
- The Biology of Cancer Invasion and MetastasisPublished by Elsevier ,1978